These compounds may interact with:
Urokinase-type plasminogen activator
Potentially involved in: substance-related disorder; carcinoma; crohn's disease; cancer; severe combined immunodeficiency; acute myocardial infarction; adenocarcinoma; alzheimer's disease; angina pectoris; angina, unstable; anuria; arterial occlusive diseases; asthma; bone neoplasms; carcinoma, transitional cell; carotid artery diseases; intracranial embolism and thrombosis; cerebral infarction; brain ischemia; cerebrovascular disorders
Disease data sourced from Pharos.